Benjamin Micah Collman is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of therapeutic compositions, particularly in the treatment of human immunodeficiency virus (HIV). With a total of 2 patents, Collman has demonstrated his commitment to advancing medical science and improving patient outcomes.

Latest Patents

Collman's latest patents focus on solid oral dosage forms for the treatment of HIV. The first patent describes a composition that includes a compound of Formula I or a pharmaceutically acceptable salt thereof, tenofovir alafenamide, and emtricitabine. This innovative approach aims to enhance the effectiveness of HIV treatment through improved drug delivery methods.

Career Highlights

Collman is currently associated with Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on antiviral drugs. His work at Gilead has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.

Collaborations

Some of Collman's notable coworkers include Lei Hong and Joanna M Koziara. Their collaborative efforts have played a crucial role in advancing the research and development of therapeutic compositions for HIV treatment.

Conclusion

Benjamin Micah Collman is a distinguished inventor whose work has significantly impacted the field of HIV treatment. His innovative patents and collaborations with esteemed colleagues highlight his dedication to improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.